Cost Estimation of First-Line Antiretroviral Therapy with Zidovudine/Stavudine as the Nucleoside Backbone in India: A Pilot Study

Conclusion:
Current treatment is associated with toxicity, increasing treatment costs and imposing a significant economic burden.

Source: Journal of the International Association of Physicians in AIDS Care (JIAPAC) - March 18, 2015 Category: Infectious Diseases Authors: Thuppal, S. V., Karthik, R., Abraham, O. C., Wanke, C. A., Mwamburi, M., Terrin, N., Cohen, J. T., Mathai, D., Muliyil, J., Kang, G. Tags: Antiretroviral Therapy Source Type: research